How do I find a clinician who will switch me?

Most GLP-1 telehealth services (Sequence/Weight Watchers, Found, Calibrate, etc.) will switch you between semaglutide and tirzepatide if you ask. They're both branded GLP-1s for weight loss, so the prescribing decision is straightforward. Bring real numbers — your starting weight, current weight, current dose, plateau date, and reason for switching.

Can I use compounded tirzepatide for the switch?

Compounded tirzepatide largely disappeared after FDA enforcement in late 2024. A small number of compounding pharmacies still operate via medical necessity exemptions, but supply is limited + quality is variable. Most switchers in 2026 use branded Mounjaro or Zepbound through insurance or pay cash retail.

Will I lose weight faster on tirzepatide than I did on semaglutide?

Usually yes, but not in the first 4-6 weeks of the switch. Semaglutide's tail keeps you covered during the early tirzepatide titration window. The accelerated loss kicks in around weeks 6-10 once you're at tirzepatide 7.5-10 mg and the semaglutide signal has fully washed out.

Is the side-effect profile worse on tirzepatide vs semaglutide?

Mixed. Tirzepatide is slightly more constipating; semaglutide is slightly more nauseating on average. The GIP arm of tirzepatide produces some unique symptoms (hiccups, occasional taste changes) that semaglutide doesn't. Both are tolerable for the vast majority of users at their final maintenance dose. The transition window is harder than steady-state on either drug.

What if I want to switch back to semaglutide later?

Reverse protocol works — drop tirzepatide, start semaglutide at one step below your equivalent dose, titrate back up. The bridge-overlap principle applies in either direction. Users sometimes switch back if tirzepatide's side effects are intolerable at the doses needed for continued weight loss, or if cost/insurance forces the change.

Semaglutide to Tirzepatide Switch Protocol: Dose Math +

Key Takeaway

Switching from Wegovy/Ozempic to Mounjaro/Zepbound is the most-asked transition in the GLP-1 community. Here is the dose-conversion math, the week-by-week protocol, and the side-effect pitfalls to plan for.

Key Takeaway

The right semaglutide → tirzepatide conversion isn't 1:1. Most users at semaglutide 2.4 mg/week land near tirzepatide 10-12.5 mg/week after 8-12 weeks of titration. The switch typically produces another 4-7% body-weight loss beyond what semaglutide alone delivered. The biggest mistake: starting tirzepatide at full equivalent dose — you'll get a GI side-effect rebound that nobody expects.

why people switch

Semaglutide (Wegovy/Ozempic) is the OG GLP-1 agonist for weight loss. STEP-1 PMID: 33567185 showed 14.9% mean body-weight loss at 2.4 mg/week over 68 weeks. Real-world results lag the trial average — most clinic data sits at 8-12% over a year.

Tirzepatide (Mounjaro/Zepbound) is the GLP-1 + GIP dual agonist. SURMOUNT-1 PMID: 35658024 hit 22.5% mean body-weight loss at 15 mg/week over 72 weeks. The dual receptor mechanism (the GIP arm potentiates GLP-1 + has direct adipose effects) is why the effect size is meaningfully bigger.

Three reasons users switch:

Plateaued on semaglutide. Hit a wall at month 6-9, no more weight coming off despite full dose + caloric deficit.
Lost 10-12% but want the trial-class outcome. Tirzepatide's extra 4-7% absolute is the gap between "lost a meaningful amount" and "no longer overweight."
Insurance switched. Plan dropped Wegovy coverage but kept Zepbound (or vice versa).

When NOT to switch

Tolerating semaglutide well + still losing weight + happy with cost is not a reason to switch. The protocol takes 8-12 weeks before tirzepatide's bigger effect overtakes what you were already getting. Plan for a temporary slowdown during the transition.

the dose conversion math

There's no official conversion table — tirzepatide and semaglutide are different molecules with different pharmacology. The clinical convention that emerged from the SURPASS + SURMOUNT trials roughly maps:

Semaglutide 0.25 mg

≈ Tirzepatide 2.5 mg

Semaglutide 0.5 mg

≈ Tirzepatide 5 mg

Semaglutide 1.0 mg

≈ Tirzepatide 7.5 mg

Semaglutide 1.7 mg

≈ Tirzepatide 10 mg

Semaglutide 2.4 mg

≈ Tirzepatide 12.5-15 mg

These are equivalents at *steady-state*, not what to use for the transition dose. Starting at the equivalent dose is the most common switching mistake — you'll trigger a fresh wave of GI side effects because tirzepatide adds GIP-receptor agonism that semaglutide users haven't built tolerance to.

Don't jump in at the equivalent dose

Even though tirzepatide 12.5 mg matches semaglutide 2.4 mg on weight-loss potency, the GIP arm is novel pharmacology for a semaglutide user. Start one step lower than the equivalent and titrate up from there.

week-by-week protocol

The clinically recommended protocol (consistent with what most telehealth GLP-1 clinics use):

Week 0 — last semaglutide dose

Take your final semaglutide dose on your normal injection day. Semaglutide has a ~165-hour half-life, so its activity persists for ~7-10 days after the last dose. You're not "washing out" before tirzepatide — you're overlapping, intentionally.

Week 1 — switch day

Inject tirzepatide 2.5 mg on the day your next semaglutide dose would have been. Yes, this is much lower than your semaglutide-equivalent dose. The semaglutide tail is still active, so you're not running on a low dose — you're getting bridge coverage.

Injection site

Use the same injection-site rotation you used with semaglutide — abdomen, thigh, or upper arm. Subcutaneous, with a fresh needle. Take it on the same day of the week you took semaglutide. Don't switch days during the transition.

Weeks 2-4 — hold or titrate up to 5 mg

If you tolerate week 1 (mild GI is normal, severe nausea is not) — escalate to tirzepatide 5 mg at week 4. If week 1 produced severe nausea, hold 2.5 mg for another 2 weeks before escalating.

Weeks 4-8 — titrate to 7.5 mg, then 10 mg

Escalate by 2.5 mg every 4 weeks. Most semaglutide-2.4-mg users land somewhere between tirzepatide 7.5 and 10 mg by week 8. This is where you'll start seeing additional weight loss beyond what semaglutide gave you.

Weeks 12+ — find your maintenance dose

If you were on semaglutide 2.4 mg, your tirzepatide maintenance dose will likely be 10-15 mg. Push higher only if weight loss has stalled at 10 mg and you tolerate the side effects.

what to expect during transition

Plateau during transition is normal

Weight loss usually slows or stalls for 2-4 weeks during the transition. The semaglutide tail is fading, the tirzepatide signal is still ramping. Don't panic — the curve resumes around week 5-6 as tirzepatide hits its therapeutic window.

Typical added weight loss at 6 months post-switch

4-7% body weight

The SURPASS-2 trial PMID: 34170647 directly compared tirzepatide 5/10/15 mg vs semaglutide 1 mg over 40 weeks in T2D patients. Tirzepatide 15 mg produced 11.2 kg weight loss vs semaglutide 1 mg's 5.7 kg — roughly double the effect. Real-world switchers (going from a higher semaglutide dose to an equivalent tirzepatide dose) see smaller deltas, but the 4-7% extra is the typical 6-month outcome.

side-effect transitions

GI profile resets at each new dose

Even if you completely adapted to semaglutide's nausea, your body sees tirzepatide as a new drug. Plan for 2-4 weeks of mild-to-moderate GI symptoms at each new tirzepatide dose level.

Common transition symptoms:

Nausea, especially evenings — eat smaller meals, no heavy fats during titration weeks
Constipation — tirzepatide is mildly more constipating than semaglutide; double down on hydration + fiber
Hiccups — uncommon but bizarre tirzepatide side effect, usually resolves in days
Heart rate slightly elevated — typically +3-5 bpm; resolves at steady-state

If GI symptoms are severe at any dose, hold that dose for an extra 2-4 weeks rather than escalating. Time + dose stability beat aggressive titration.

common mistakes

Mistake #1: skipping the bridge week

Stopping semaglutide and waiting 2 weeks before starting tirzepatide produces a real appetite rebound + weight regain that takes 4-6 weeks to recover from. Don't do this — overlap the doses.

Mistake #2: pushing the dose too fast. Going semaglutide 2.4 mg → tirzepatide 5 mg → 7.5 mg → 10 mg → 12.5 mg over 8 weeks because you "want to get to the maintenance dose fast" usually means a month of significant GI distress and often a discontinuation. Slow titration wins.

Mistake #3: stacking with another GLP-1 or GLP-1+ agonist. Adding semaglutide or retatrutide to a tirzepatide stack is mechanistically redundant (GLP-1 receptor saturation) and dramatically raises GI side-effect risk. Pick one agonist + dose it appropriately.

Mistake #4: not adjusting diet during transition. Tirzepatide's appetite suppression is meaningfully stronger than semaglutide's at equivalent doses. Many switchers eat 200-400 calories less than they did on semaglutide without trying — you may need to deliberately keep protein intake up + add electrolytes to avoid lean-mass loss + fatigue.

Track protein floor

0.7-1.0 g protein per pound lean body mass. GLP-1 weight loss includes lean mass loss if protein intake drops. Most failed-recomp stories on Reddit are users who dropped to 60-80g protein/day without realizing it because they're never hungry.

after 8 weeks: how to know it's working

You've successfully completed the switch if:

Weight loss curve has resumed (typically 1-2 lbs/week at maintenance)
GI side effects have stabilized at a tolerable level
Energy + sleep are similar to pre-switch
You're not constantly hungry between meals

If you're 8+ weeks in and weight has stalled, the next moves (in order):

Increase tirzepatide dose by one step (5 → 7.5, 7.5 → 10, etc.)
Re-audit calorie + protein intake — most stalls are diet drift, not drug failure
Add resistance training if not already in your routine
Consider retatrutide if you're on tirzepatide 15 mg and still stalled (see the tirzepatide → retatrutide switch protocol)

Compare every angle — trial data, cost, mechanism

Head-to-head walk-through with vendor pricing

Full deep-dive: tirzepatide vs semaglutide

Frequently asked

Start tirzepatide at 2.5 mg as the protocol says. Don't try to map your sub-maintenance semaglutide dose directly. The 2.5 mg starting dose is gentle enough for any user regardless of where you ended up on semaglutide. Titrate normally from there.

Share this article:𝕏 / Twitter

BioChonchFounder & Lead Researcher

Founder, BodyHackGuide

|About the author